The Food and Drug Administration (FDA) has imposed restrictions on the prescription of drugs containing montelukast for people with allergic rhinitis, ruling that such medications should only be prescribed after other drugs have been used and failed to be effective.
Drugs containing montelukast could affect a person’s mental health while they are taking the medication or after treatment has stopped, with side effects including changes in behavior, unusual movements or suicidal thoughts, the FDA said in a statement yesterday.
Hung Kuo-teng (洪國登), head of the FDA’s Medicinal Products Division, told reporters that there are 31 drug permit licenses that have been issued in Taiwan for medications containing montelukast, which is used to treat asthma and allergic rhinitis, a type of nasal inflammation that occurs when the immune system overreacts to allergens in the air.
Citing National Health Insurance data, Hung said that each year, about 900,000 prescriptions of medication containing montelukast are given out.
Last year, the US Food and Drug Administration issued a warning against drugs containing montelukast, saying that their clinical effectiveness was not shown to be greater than the potential risk they posed to people’s mental health.
It then determined that they should not be used until other medications for allergic rhinitis have been used and found to be ineffective, Hung said.
In light of the warning, Taiwan’s FDA re-evaluated the effectiveness and risk of such medications, and its drug safety assessment panel determined that while drugs containing montelukast are effective in treating allergic rhinitis, they might also cause people to develop mental health problems, Hung said.
As a result, the agency has decided to list those medications as “rear-line” drugs, meaning that they can only be prescribed when other medications for nasal inflammation caused by allergies have failed to be effective, Hung said, adding that there are other drugs for treating asthma.
The ruling went into effect immediately.
The companies that hold permit licenses for drugs containing montelukast have been told to change the content of their package inserts before July 31 so that they state that the drugs can only be used when other medications for allergic rhinitis have failed to be effective, Hung said.
Companies that fail to make the change before the deadline would have their drug permit license revoked, Hung said.
ANOTHER EMERGES: The CWA yesterday said this year’s fourth storm of the typhoon season had formed in the South China Sea, but was not expected to affect Taiwan Tropical Storm Gaemi has intensified slightly as it heads toward Taiwan, where it is expected to affect the country in the coming days, the Central Weather Administration (CWA) said yesterday. As of 8am yesterday, the 120km-radius storm was 800km southeast of Oluanpi (鵝鑾鼻), Taiwan’s southernmost tip, moving at 9kph northwest, the agency said. A sea warning for Gaemi could be issued tonight at the earliest, it said, adding that the storm is projected to be closest to Taiwan on Wednesday or Thursday. Gaemi’s potential effect on Taiwan remains unclear, as that would depend on its direction, radius and intensity, forecasters said. Former Weather Forecast
As COVID-19 cases in Japan have been increasing for 10 consecutive weeks, people should get vaccinated before visiting the nation, the Centers for Disease Control (CDC) said. The centers reported 773 hospitalizations and 124 deaths related to COVID-19 in Taiwan last week. CDC Epidemic Intelligence Center Director Guo Hung-wei (郭宏偉) on Tuesday said the number of weekly COVID-19 cases reported in Japan has been increasing since mid-May and surpassed 55,000 cases from July 8 to July 14. The average number of COVID-19 patients at Japan’s healthcare facilities that week was also 1.39 times that of the week before and KP.3 is the dominant
The Chinese Communist Party’s (CCP) working group for Taiwan-related policies is likely to be upgraded to a committee-level body, a report commissioned by the Mainland Affairs Council (MAC) said. As Chinese President Xi Jinping (習近平) is increasingly likely to upgrade the CCP’s Central Leading Group for Taiwan Affairs, Taiwanese authorities should prepare by researching Xi and the CCP, the report said. At the third plenary session of the 20th Central Committee of the CCP, which ended on Thursday last week, the party set a target of 2029 for the completion of some tasks, meaning that Xi is likely preparing to
US-CHINA TRADE DISPUTE: Despite Beijing’s offer of preferential treatment, the lure of China has dimmed as Taiwanese and international investors move out Japan and the US have become the favored destinations for Taiwanese graduates as China’s attraction has waned over the years, the Ministry of Labor said. According to the ministry’s latest income and employment advisory published this month, 3,215 Taiwanese university graduates from the class of 2020 went to Japan, surpassing for the first time the 2,881 graduates who went to China. A total of 2,300 graduates from the class of 2021 went to the US, compared with the 2,262 who went to China, the document showed. The trend continued for the class of 2023, of whom 1,460 went to Japan, 1,334 went to